ex-vivo GBA stem cell-based gene therapy (Clinical Technology Centre)

N/A

Report date: 2025/03/20 16:00:04

Base Information

Drug Nameex-vivo GBA stem cell-based gene therapy (Clinical Technology Centre)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionBeta-glucocerebrosidase stimulants
TargetsBeta-glucocerebrosidase
Therapy Area/IndicationsGaucher Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesClinical Technology Centre (International) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesClinical Technology Centre (International) Ltd
Inactive CompaniesN/A
Active IndicationsGaucher Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A